Quote: Originally Posted by egofed Is it also false that the affluent of other socialized healthcare countries routinely come here to enjoy our ease of accessibility to advanced procedures?

So making the (what I consider very reasonable) assumptions that:

1. The affluent of other countries come here for advanced medical treatment and procedures (your words)
2. Said affluent purchase insurance above their own countries socialized systems, giving them access to our advanced procedures
3. Our own poor, even with Obamacare, will not have access to the most advanced medical treatment and procedures (ie OMG DEATH PANELS)
4. Our own affluent will also purchase insurance above coverage by Obamacare in order to maintain access to advanced medical treatment and procedures

Given those very logical conclusions, where is the money constraint on the part of our healthcare industry that researches advanced medical treatment and procedures? Surely it's not the poor, who won't have access to the new hotness. But they don't now, so nothing changes there. The rich will obviously continue to use these high end services given their current consumption habits. So what part of the market changes? What part of Obamacare fundamentally changes the landscape that creates this future of reduced investment in medical advancement?

I don't get it.

__________________